HTC
AVNS icon

Haverford Trust Company’s Avanos Medical AVNS Stock Holding History

Haverford Trust Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,285
Closed -$1.01M – 228
2014
Q4 		$1.01M Buy
+22,285
New +$876K 0.03% 121

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Haverford Trust Company's AVNS Position: Q1 2015 in Review

Haverford Trust Company sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 22,285 shares — an estimated $1.01M sold.

Haverford Trust Company first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $1.01M in Q4 2014. 447 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Haverford Trust Company reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
  • Haverford Trust Company sold 22,285 Avanos Medical shares in Q1 2015, an estimated $1.01M.
  • Haverford Trust Company first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
  • Haverford Trust Company's Avanos Medical position peaked at $1.01M in Q4 2014.
  • 447 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Haverford Trust Company's 13F filing for Q1 2015, filed 4 May 2015.